rs387907057
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015346.4(ZFYVE26):c.5422C>T(p.Gln1808Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015346.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZFYVE26 | NM_015346.4 | c.5422C>T | p.Gln1808Ter | stop_gained | 28/42 | ENST00000347230.9 | |
ZFYVE26 | XM_047431173.1 | c.5422C>T | p.Gln1808Ter | stop_gained | 28/42 | ||
ZFYVE26 | XM_047431174.1 | c.3097C>T | p.Gln1033Ter | stop_gained | 17/31 | ||
ZFYVE26 | XM_047431175.1 | c.3004C>T | p.Gln1002Ter | stop_gained | 17/31 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZFYVE26 | ENST00000347230.9 | c.5422C>T | p.Gln1808Ter | stop_gained | 28/42 | 1 | NM_015346.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249292Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134676
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460596Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726502
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 15 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Paris Brain Institute, Inserm - ICM | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 06, 2009 | - - |
Spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 05, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 30933). This premature translational stop signal has been observed in individual(s) with clinical features of hereditary spastic paraplegia (PMID: 19805727). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Gln1808*) in the ZFYVE26 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZFYVE26 are known to be pathogenic (PMID: 18394578, 19805727). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at